In this episode of the "Vibe Science" podcast, hosts Ryan Alford and Chris Hanson interview Paul Austin, founder of Third Wave, about the evolving perceptions and therapeutic potential of psychedelics, with a focus on microdosing. Paul shares his personal journey and insights into the history and current landscape of psychedelics, discussing their medical applications and the societal stigma surrounding them. The conversation touches on recent legalization efforts, the impact of COVID-19 on mental health and psychedelic use, and the promising future of psychedelics in mental health treatment. Ryan and Chris emphasize the importance of open discussions about these substances.TAKEAWAYS Evolving perceptions of psychedelics and microdosing Therapeutic benefits of psychedelics for mental health Personal journeys and experiences with psychedelics Societal stigma surrounding psychedelic use Recent legalization efforts for psychedelics in various states Impact of COVID-19 on mental health and psychedelic use Historical context and evolution of psychedelic use Importance of safe and regulated therapeutic settings Microdosing as an accessible entry point for new users Future potential of psychedelics in mental health treatment TIMESTAMPSIntroduction to Vibe Science (00:00:00)Introduction of the podcast, hosts Ryan Alford and Chris Hanson.Welcoming Paul Austin (00:00:36)Hosts welcome guest Paul Austin, founder of Third Wave, discussing his influence in the psychedelic space.Stigmatization of Psychedelics (00:01:35)Ryan shares his evolving views on psychedelics and their potential therapeutic benefits.Legalization Efforts (00:02:25)Paul discusses recent legalization of psilocybin mushrooms in Colorado and Oregon, and decriminalization in several cities.Historical Context of Psychedelics (00:05:13)Paul reflects on his journey with psychedelics and their historical use in society.The Third Wave Concept (00:06:14)Paul explains the concept of Third Wave, integrating ancient and modern perspectives on psychedelics.Psychedelics vs. Traditional Drugs (00:14:36)Discussion on the safety and potential of psychedelics compared to traditional substances like alcohol and tobacco.Cultural Shifts and Milestones (00:16:56)Paul outlines key milestones in the psychedelic movement, including Michael Pollan's influential book.Impact of COVID-19 (00:18:59)The pandemic increased psychedelic use and interest in mental health treatments, including ketamine therapy.Future of Psychedelics (00:20:05)Paul predicts widespread legal access to psychedelics in the coming years, driven by public support and clinical research.Personal Journey with Psychedelics (00:22:20)Paul shares his personal experience with psychedelics and their impact on processing emotions.Advocacy for Psychedelics (00:23:20)Paul discusses his strong belief in psychedelics as powerful tools for emotional and spiritual healing.Understanding Different Substances (00:24:26)Paul explains the various psychedelics and their distinct experiences, emphasizing the importance of substance choice.Therapeutic Use of Ketamine (00:27:19)The therapeutic applications of ketamine are discussed, including its benefits for depression and suicidality.Risks of Ketamine Use (00:28:36)Paul highlights the dangers of unsupervised ketamine use and the importance of a safe therapeutic setting.Microdosing Benefits (00:29:57)Microdosing benefits are outlined, focusing on improved mood, energy, and sleep without significant intoxication.Ketamine Therapy Experience (00:30:30)Discussion on whether patients talk during ketamine therapy sessions, depending on the dosage used.Navigating Emotional Release (00:32:29)The conversation addresses the balance between emotional vulnerability and resilience, especially for men.Mindset and Psychedelics (00:34:02)Paul emphasizes the importance of mindset when using psychedelics for personal development and resilience.Personal Development vs. Recreational Use (00:36:30)The distinction between using psychedelics for personal growth versus recreational enjoyment is explored.Self-Regulation and Responsibility (00:38:32)The need for self-regulation in substance use is discussed to avoid dependency.Starting with Psychedelics (00:39:58)Paul advises beginners on how to approach psychedelics safely and responsibly, starting with microdosing.Credibility in Psychedelic Discussions (00:42:01)Ryan praises Paul for his in-depth knowledge and credible approach to discussing psychedelics.Resources for Learning More (00:42:56)Paul shares where listeners can find more information about psychedelics and microdosing through Third Wave.Personal Contact Information (00:43:17)Paul shares his social media handles for listeners to reach out with questions.Appreciation and Credibility (00:43:30)Ryan expresses gratitude for Paul's insights and credibility during the episode.Acknowledgment of Hosts (00:43:37)Paul thanks Ryan and Chris for their contributions and sharing their stories.Excitement for Episode Release (00:43:44)Chris shares his enthusiasm for the episode's release and its potential impact on listeners.Episode Summary and Resources (00:43:51)Ryan provides information on where to find episode highlights, full episodes, and guest resources.Medical Disclaimer (00:44:04)Ryan emphasizes that the content is for educational purposes and not medical advice.Closing Remarks (00:44:12)Ryan thanks listeners and encourages them to visit the podcast website for more information. Follow us on Instagram: @Vibe.Science Subscribe to our YouTube Page: www.youtube.com/@Vibe.Science Visit our homepage www.VibeScience.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related